Glaucoma Implants | LIQID Medical

Redefining
the treatment of
Glaucoma

Fighting Blindness

LIQID Medical is pioneering two novel ocular implants designed to become the new gold standard for treating glaucoma, the leading cause of irreversible blindness worldwide. Our suite of implants aims to provide surgeons with a new, patient-centric paradigm for surgically treating glaucoma.

The Future Treatment Paradigm

The QMAX is designed to circumvent the major sources of complications associated with current glaucoma treatment surgeries by facilitating the drainage of aqueous fluid into a naturally occurring fluid reservoir around the optic nerve. The QMAX is aims to become the new gold standard of care.

The QFLOW is a Minimally Invasive Glaucoma Surgery “MIGS” device that leverages and improves on existing devices. The QFLOW was developed with input from leading glaucoma surgeons around the world to create the ideal bleb-forming glaucoma device.

The QFLOW is a Minimally Invasive Glaucoma Surgery “MIGS” device that leverages and improves on existing devices. The QFLOW was developed with input from leading glaucoma surgeons around the world to create the ideal bleb-forming glaucoma device.

Glaucoma: The leading cause of irreversible blindness

Glaucoma is a chronic disease that causes permanent damage to the optic nerve and is the leading cause of irreversible blindness worldwide. The major risk factor for developing glaucoma is elevated eye pressure. Elevated IOP damages the optic nerve due to an increased pressure difference across the optic nerve head, causing damage to the optic nerve fibers.

112